Literature DB >> 25486351

Fasting levels of hepatic p-S6 are increased in old mice.

Olga V Leontieva1, Geraldine M Paszkiewicz, Mikhail V Blagosklonny.   

Abstract

TOR is involved in aging in a wide range of species from yeast to mammals. Here we show that, after overnight fasting, mTOR activity is higher in the livers of 28 months old female mice compared with middle-aged mice. Taken together with previous reports, our data predict that the life-extending effect of calorie restriction (CR) may be diminished, if CR is started in very old age. In contrast, rapamycin is known to be effective, even when started late in life.

Entities:  

Keywords:  aging; mTOR; rapalogs; rapamycin; senescence

Mesh:

Substances:

Year:  2014        PMID: 25486351      PMCID: PMC4612665          DOI: 10.4161/15384101.2014.949150

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  57 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

2.  Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration.

Authors:  Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2009-06-21       Impact factor: 4.534

Review 3.  Senescence regulation by mTOR.

Authors:  Vjekoslav Dulic
Journal:  Methods Mol Biol       Date:  2013

Review 4.  mTOR signaling as a target of amino acid treatment of the age-related sarcopenia.

Authors:  Giuseppe D'Antona; Enzo Nisoli
Journal:  Interdiscip Top Gerontol       Date:  2010-08-10

5.  Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans).

Authors:  Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2010-03-02       Impact factor: 4.534

6.  Hypoxia suppresses conversion from proliferative arrest to cellular senescence.

Authors:  Olga V Leontieva; Venkatesh Natarajan; Zoya N Demidenko; Lyudmila G Burdelya; Andrei V Gudkov; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

7.  Rapamycin extends life and health in C57BL/6 mice.

Authors:  Yiqiang Zhang; Alex Bokov; John Gelfond; Vanessa Soto; Yuji Ikeno; Gene Hubbard; Vivian Diaz; Lauren Sloane; Keith Maslin; Stephen Treaster; Samantha Réndon; Holly van Remmen; Walter Ward; Martin Javors; Arlan Richardson; Steven N Austad; Kathleen Fischer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-16       Impact factor: 6.053

8.  Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival.

Authors:  Fresnida J Ramos; Steven C Chen; Michael G Garelick; Dao-Fu Dai; Chen-Yu Liao; Katherine H Schreiber; Vivian L MacKay; Elroy H An; Randy Strong; Warren C Ladiges; Peter S Rabinovitch; Matt Kaeberlein; Brian K Kennedy
Journal:  Sci Transl Med       Date:  2012-07-25       Impact factor: 17.956

9.  Rapamycin slows aging in mice.

Authors:  John E Wilkinson; Lisa Burmeister; Susan V Brooks; Chi-Chao Chan; Sabrina Friedline; David E Harrison; James F Hejtmancik; Nancy Nadon; Randy Strong; Lauren K Wood; Maria A Woodward; Richard A Miller
Journal:  Aging Cell       Date:  2012-06-04       Impact factor: 9.304

10.  Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium.

Authors:  O V Leontieva; Z N Demidenko; M V Blagosklonny
Journal:  Cell Death Dis       Date:  2014-05-08       Impact factor: 8.469

View more
  13 in total

Review 1.  The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.

Authors:  Brian K Kennedy; Dudley W Lamming
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

2.  Comparison of rapamycin schedules in mice on high-fat diet.

Authors:  Olga V Leontieva; Geraldine M Paszkiewicz; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

3.  Gerosuppression in confluent cells.

Authors:  Olga V Leontieva; Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2014-12       Impact factor: 5.682

Review 4.  Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging Molecules.

Authors:  Surinder Kumar; David B Lombard
Journal:  F1000Res       Date:  2016-03-29

5.  Analysis of plasma microRNA expression profiles revealed different cancer susceptibility in healthy young adult smokers and middle-aged smokers.

Authors:  Bing Shi; Hongmin Gao; Tianyang Zhang; Qinghua Cui
Journal:  Oncotarget       Date:  2016-04-19

6.  Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice.

Authors:  Emma L Baar; Kathryn A Carbajal; Irene M Ong; Dudley W Lamming
Journal:  Aging Cell       Date:  2015-11-24       Impact factor: 9.304

7.  Overactive mTOR signaling leads to endometrial hyperplasia in aged women and mice.

Authors:  Preety Bajwa; Sarah Nielsen; Janine M Lombard; Loui Rassam; Pravin Nahar; Bo R Rueda; J Erby Wilkinson; Richard A Miller; Pradeep S Tanwar
Journal:  Oncotarget       Date:  2017-01-31

8.  Rapamycin increases grip strength and attenuates age-related decline in maximal running distance in old low capacity runner rats.

Authors:  Qian-Li Xue; Huanle Yang; Hui-Fen Li; Peter M Abadir; Tyesha N Burks; Lauren G Koch; Steven L Britton; Joshua Carlson; Laura Chen; Jeremy D Walston; Sean X Leng
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

9.  Age related increase in mTOR activity contributes to the pathological changes in ovarian surface epithelium.

Authors:  Preety Bajwa; Prathima B Nagendra; Sarah Nielsen; Subhransu S Sahoo; Amanda Bielanowicz; Janine M Lombard; J Erby Wilkinson; Richard A Miller; Pradeep S Tanwar
Journal:  Oncotarget       Date:  2016-04-12

Review 10.  Evidence that a mitochondrial death spiral underlies antagonistic pleiotropy.

Authors:  Michael Stern
Journal:  Aging Cell       Date:  2017-02-09       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.